Neointimal smooth muscle cell phenotype is important in its susceptibility to cytomegalovirus (CMV) infection: A study in rat

Cardiovascular Research

Volumn 36, Issue 2, 1997, Pages 282-288

  Persoons, Maike C J ^a   Daemen, Mat J A P ^a   Van Kleef, Ellen M ^a   Grauls, Gert E L M ^a   Wijers, Edwin ^a   Bruggeman, Cathrien A ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ACTIN; DESMIN; VIMENTIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BALLOON CATHETER; CAROTID ARTERY; CELL STRUCTURE; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; IMMUNOHISTOCHEMISTRY; INFECTION SENSITIVITY; INTIMA; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; RAT; SMOOTH MUSCLE FIBER;

ANALYSIS OF VARIANCE; ANIMALS; ANTIGENS, VIRAL; BALLOON DILATATION; BIOLOGICAL MARKERS; CAROTID ARTERY INJURIES; CAROTID ARTERY, COMMON; CELL DIFFERENTIATION; CELL DIVISION; CYTOMEGALOVIRUS INFECTIONS; DESMIN; DISEASE SUSCEPTIBILITY; MUSCLE, SMOOTH, VASCULAR; RANDOM ALLOCATION; RATS; RATS, INBRED WKY; TIME FACTORS; TUNICA INTIMA;

EID: 0031282170     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(97)00189-2     Document Type: Article

References (29)

1. Petrie B.L., Melnick J.L., Adam E., Burek J., McCollum C.H., DeBakey M.E. Nucleic acid sequences of cytomegalovirus in cells cultured from human arterial tissue. J Infect Dis. 155:1987;158-159.
2. Yamashiroya H.M., Ghosh L., Yang R., Robertson A.L. Herpesviridae in the coronary arteries and aorta of young trauma victims. Am J Pathol. 130:1988;71-79.
3. Hendrix M.G.R., Dormans P.H.J., Kitselaar P., Bosman F., Bruggeman C.A. The presence of CMV nucleic acids in arterial walls of atherosclerotic and non-atherosclerotic patients. Am J Pathol. 134:1989;1151-1157.
4. Grattan M.T., Moreno-Cabral C.E., Starnes V.A., Oyer P.E., Stinson E.B., Shumway N.E. Cytomegalovirus infection is associated with cardiac allograft rejection and atherosclerosis. JAMA. 261:1989;3561-3566.
5. McDonald K., Rector T.S., Braunlin T.A., Kubo S.H., Olvari M.T. Association of coronary artery disease in cardiac transplant recipients with cytomegalovirus infection. Am J Pathol. 64:1989;359-362.
6. Bruning J.H., Persoons M.C.J., Lemstrom K.B., Stals F.S., De Clereq E., Bruggeman C.A. Enhancement of transplantation associated atherosclerosis by CMV, which can be prevented by antiviral therapy in the form of HPMPC. Transplant Int. 7(suppl 1):1994;365-370.
7. Lemström K.B., Bruning J.H., Bruggeman C.A., Lautenschlager I.T., Häyry P.J. Cytomegalovirus infection enhances smooth muscle cell proliferation and intimal thickening of rat aortic allografts. J Clin Invest. 92:1993;549-558.
8. Lemström K., Koskinen P., Krogerus L., Daemen M., Bruggeman C., Häyry P.J. Cytomegalovirus antigen expression, endothelial cell proliferation, and intimal thickening in rat cardiac allografts after cytomegalovirus infection. Circulation. 92:1995;2594-2604.
9. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 362:1993;801-809.
10. Desmouilière A., Gabbiani G. The role of arterial smooth muscle cells in the pathogenesis of atherosclerosis. Cerebrovasc Dis. 2:1992;63-71.
11. Schwartz S.M., de Blois D., O'Brien E.R.M. The intima. Soil for atherosclerosis and restenosis. Circ Res. 77:1995;445-465.
12. Persoons M.C.J., Daemen M.J.A.P., Bruning J.H., Bruggeman C.A. Active cytomegalovirus infection of arterial smooth muscle cells immunocompromised rats. A clue to herpesvirus associated atherogenesis? Circ Res. 75:1994;214-220.
13. Speir E., Modali R., Huang E.S., Leon M.B., Shawl F., Finkel T., Epstein S.E. Potential role of human cytomegalovirus and p53 interaction in coronary restenosis. Science. 265:1994;391-394.
14. Zhou Y.F., Leon M.B., Wlacawiw M.A., Popma J.J., Yu Z.X., Finkel T., Epstein S.E. Association between prior cytomgalovirus infection and the risk of restenosis after coronary atherectomy. New Engl J Med. 335:1996;624-630.
15. Kocher O., Gabbiani F., Gabbiani G., Reidy M., Cokay M.S., Peters H., Hüttner I. Phenotypic features of smooth muscle cells during the evolution of experimental carotid artery intmal thickening. Biochemical and morphologic studies. Lab Invest. 65:1991;459-470.
16. Orlandi A., Ehrlich P., Ropraz P., Spagnoli L.G., Gabbiani G. Rat aortic smooth muscle cells isolated from different layers and at different times after endothelial denudation show distinct biological features in vitro. Arterioscler Thromb. 14:1994;982-989.
17. Bruggeman C.A., Meijer H., Dormans P.H.J., Debie W.H.M., Grauls G.E.L.M., van Boven C.P.A. Isolation of a cytomegalovirus-like agent from wild rats. Arch Virol. 73:1982;231-241.
18. Stals F.S., Bosman F., van Boven C.P.A., Bruggeman C.A. An animal model for therapeutic intervention studies of CMV infection in the immunocomprimised host. Arch Virol. 114:1990;91-107.
19. Clowes A.W., Reidy M.A., Clowes M.M. Kinetics of cellular proliferation after arterial injury. I. Smooth muscle cell growth in the absence of endothelium. Lab Invest. 49:1983;327-333.
20. Bruning J.H., Debie W.H.M., Dormans P.H.J., Meijer H., Bruggeman C.A. The development and characterisation of monoclonal antibodies against rat cytomegalovirus induced antigens. Arch Virol. 94:1987;55-70.
21. Post M.J., Borst C., Kuntz R.E. The relative importance of arterial remodelling compared with intimal hyperplasia in lumen narrowing after balloon angioplasty. A study in the normal rabbit and the hypercholesterolemic Yucatan micropig. Circulation. 89:1994;2937-2941.
22. Kakuta T., Currier J.W., Haudenschild C.C., Ryan T.J., Faxon D.P. Differences in compensatory vessel enlargement, not intimal formation, account for restenosis after angioplasty in the hypercholesteremic rabbit model. Circulation. 89:1994;2809-2815.
23. Lafont A., Guzman L.A., Whitlow P.L., Goormastic M., Cornhill J.F., Chisolm G.M. Restenosis after experimental angioplasty. Intimal, medial, and adventitial changes associated with constrictive remodelling. Circ Res. 76:1995;996-1002.
24. Leclerc G., Kearney M., Schneider D., Rosenfield K., Losordo D.W., Isner J.M. Assessment of cell kinetics in human restenotic lesions by in vitro bromodeoxyuridine labeling of excised atherectomyspecimen. Clin Res, Abstract. 41:1993;343A.
25. O'Brien E.R., Alpers C.E., Stewart D.K., Fergusan N., Tran N., Gordon D., Benditt E., Hinohara T., Simpson J.B., Schwartz S.M. Proliferation in primary and restenotic coronary atherectomy tissue; implications for antiproliferative therapy. Circ Res. 73:1993;223-231.
26. Mosse R.L., Campbell G.R., Wang Z.L., Campbell J.H. Smooth muscle phenotypic expression in human carotid arteries. I. Comparison of cells from diffuse intimal thickenings adjacent to atheromatous plaques with those of the media. Lab Invest. 53:1985;556-562.
27. Schwartz S.M., Campbell G.R., Campbell J.H. Replication of smooth muscle cells in vascular disease. Circ Res. 58:1986;427-444.
28. Desmouiliere A, Gabbiani G. The cytoskeleton of arterial smooth muscle cells during human and experimental atheromatosis. Kidney Int 1992;41 Suppl 37:S-87 S-89.
29. Newby C.N., George S.J. Proposed roles for growth factors in mediating smooth muscle proliferation in vascular pathologies. Cardiovasc Res. 27:1993;1173-1183.